Potential interim results from the Ph 3 study in DRP with pimavanserin - investors with lower risk profile heading for the door.
Neuren - Cracking the $200m m/cap again., page-45
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.00 |
Change
-0.025(0.19%) |
Mkt cap ! $1.660B | |||
| Open | High | Low | Value | Volume |
| $13.06 | $13.26 | $12.81 | $3.987M | 307.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 364 | $12.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.00 | 1222 | 21 |
View Market Depth
| Last trade - 15.11pm 15/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |